| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
214 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,991 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,162 |
| 424/277.1 |
Cancer cell or component thereof |
426 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
226 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
222 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
147 |
| 424/193.1 |
Conjugate or complex |
918 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
103 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
1,093 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
519 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
278 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
262 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
642 |
| 424/204.1 |
Virus or component thereof |
1,086 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618942 |
Method of using broad-spectrum delta-endotoxins |
Nov. 17, 2009 |
| 7618641 |
Functionally reconstituted viral membranes containing adjuvant |
Nov. 17, 2009 |
| 7615359 |
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
Nov. 10, 2009 |
| 7615228 |
Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits |
Nov. 10, 2009 |
| 7615226 |
Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant |
Nov. 10, 2009 |
| 7615222 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Nov. 10, 2009 |
| 7612172 |
Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
Nov. 3, 2009 |
| 7612038 |
Biglycan and related therapeutics and methods of use |
Nov. 3, 2009 |
| 7611713 |
Inducing cellular immune responses to hepatitis B virus using peptide compositions |
Nov. 3, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608276 |
Staphylococcus aureus proteins and nucleic acids |
Oct. 27, 2009 |
| 7608247 |
Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation |
Oct. 27, 2009 |
| 7608246 |
Apolipoprotein E as an adjuvant for lipid antigens |
Oct. 27, 2009 |
| 7605121 |
Oligopeptide lyophilisate, their preparation and use |
Oct. 20, 2009 |
| 7604810 |
Conserved Neisserial antigens |
Oct. 20, 2009 |
| 7604809 |
Reinforcing systemic immune responses with lactobacillus casei |
Oct. 20, 2009 |
| 7604804 |
Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120 |
Oct. 20, 2009 |
| 7604803 |
Method to enhance an immune response of nucleic acid vaccination |
Oct. 20, 2009 |
| 7604802 |
Method of obtaining cellular immune responses from proteins |
Oct. 20, 2009 |
| 7601359 |
Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins |
Oct. 13, 2009 |
| 7601358 |
Mycobacterium tuberculosis protein composition |
Oct. 13, 2009 |
| 7601357 |
Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
Oct. 13, 2009 |
| 7601355 |
Compositions and methods for altering immune function |
Oct. 13, 2009 |
| 7597896 |
Composition comprising a protein encoded by a modified ERP gene of Mycobacterium |
Oct. 6, 2009 |
| 7597895 |
Signal peptides, nucleic acid molecules and methods for treatment of caries |
Oct. 6, 2009 |
| 7595060 |
Yeast-antigen compositions methods of making the same |
Sep. 29, 2009 |
| 7595057 |
Streptococcus pyogenes antigens and corresponding DNA fragments |
Sep. 29, 2009 |
| 7592421 |
HLA class II peptide mimics |
Sep. 22, 2009 |
| 7592158 |
BASB019 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses |
Sep. 22, 2009 |
| 7592135 |
High resolution typing system for pathogenic Mycobacterium tuberculosum |
Sep. 22, 2009 |
| 7592011 |
Genes and proteins, and their use |
Sep. 22, 2009 |
| 7592009 |
Polypeptide ligands for targeting cartilage and methods of use thereof |
Sep. 22, 2009 |
| 7592008 |
Membrane scaffold proteins |
Sep. 22, 2009 |
| 7591997 |
Method for determining the susceptibility of a subject to infection |
Sep. 22, 2009 |
| 7589174 |
GRP94-based compositions and methods of use thereof |
Sep. 15, 2009 |
| 7588774 |
Molecules enhancing dermal delivery of influenza vaccines |
Sep. 15, 2009 |
| 7588773 |
Methods and compositions for diagnosing and preventing a group B streptococcal infection |
Sep. 15, 2009 |
| 7588772 |
AAV capsid library and AAV capsid proteins |
Sep. 15, 2009 |
| 7588770 |
Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins |
Sep. 15, 2009 |
| 7588768 |
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
Sep. 15, 2009 |
| 7588763 |
Methods for the prevention against or treatment of diabetes with ETXB and/or insulin |
Sep. 15, 2009 |
| 7585847 |
Immunostimulatory nucleic acids for the treatment of asthma and allergy |
Sep. 8, 2009 |
| 7585510 |
Vaccine |
Sep. 8, 2009 |
| 7585509 |
Erb-2 receptor targeting peptide |
Sep. 8, 2009 |
| 7585506 |
Compositions and methods for the therapy and diagnosis of lung cancer |
Sep. 8, 2009 |
| 7582304 |
Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans |
Sep. 1, 2009 |
| 7582300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
Sep. 1, 2009 |
| 7579012 |
Targeting of triacylglycerol synthase gene for tuberculosis treatment |
Aug. 25, 2009 |
| 7579010 |
Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin |
Aug. 25, 2009 |
| 7579009 |
Whole bacterial cells as immune modulator |
Aug. 25, 2009 |
|
|
|
